Search hospitals > Florida > Tampa

University of South Florida

Claim this profile
Tampa, Florida 33612
Global Leader in Parkinson's Disease
Global Leader in Multiple Sclerosis
Conducts research for HIV Infection
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Alzheimer's Disease
633 reported clinical trials
63 medical researchers
Photo of University of South Florida in TampaPhoto of University of South Florida in Tampa

Summary

University of South Florida is a medical facility located in Tampa, Florida. This center is recognized for care of Parkinson's Disease, Multiple Sclerosis, HIV Infection, Human Immunodeficiency Virus Infection, Alzheimer's Disease and other specialties. University of South Florida is involved with conducting 633 clinical trials across 810 conditions. There are 63 research doctors associated with this hospital, such as Juan F. Rico, Maxim Mokin, PhD, Murray Shames, MD, and David Smith, MD.

Area of expertise

1Parkinson's Disease
Global Leader
University of South Florida has run 45 trials for Parkinson's Disease. Some of their research focus areas include:
Stage I
Stage II
2Multiple Sclerosis
Global Leader
University of South Florida has run 42 trials for Multiple Sclerosis.

Top PIs

Clinical Trials running at University of South Florida

Heart Failure
Stroke
Multiple Sclerosis
Seizures
Abdominal Aortic Aneurysm
Kidney Stones
Insomnia
Myasthenia Gravis
Cardio-Renal Syndrome
Epilepsy
Image of trial facility.

His Bundle vs Biventricular Pacing

for Heart Failure

The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-related complications and re-interventions (e.g., lead dislodgement, infection) relative to standard of care biventricular pacing in patients with heart failure due to left ventricular systolic dysfunction (LVEF≤50%) and with either a wide QRS (≥130 ms) or with/anticipated \>40% pacing who are already receiving current standard heart failure pharmacological therapy.
Recruiting1 award N/A4 criteria
Image of trial facility.

Aortix Device

for Heart Failure

This trial tests a device called Aortix that helps the heart pump blood better. It targets patients with severe heart failure who don't get better with usual treatments. The device works by helping the heart move blood more efficiently.
Recruiting1 award N/A5 criteria
Image of trial facility.

AccuCinch System

for Heart Failure

This trial is testing a new device called the AccuCinch Ventricular Restoration System in patients with a specific type of heart failure. The device helps the heart pump blood more effectively by supporting and reshaping its lower chamber. The study aims to see if this device, combined with standard medical treatment, is safe and effective. The CorCap Cardiac Support Device (CSD) is a predecessor that has shown safety and effectiveness in improving left ventricular structure and function in heart failure patients.
Recruiting1 award N/A9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of South Florida?
Where is University of South Florida located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of South Florida accept?
What awards or recognition has University of South Florida received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security